Oenon Holdings, Inc.
Oenon Holdings, Inc. 2026 Term 12 Interim Period Financial Summary
For the 2nd quarter of the 2026 term, consolidated net sales were 43,673 million yen (up 3.3% YoY), operating profit 2,557 million yen, ordinary profit 2,650 million yen, and net income attributable to owners of the parent 1,970 million yen. The full-year forecast remains as announced in February 2026. Buyback of treasury stock was conducted (ending period treasury stock 3,151 million yen, shares acquired 649,300).
Key Figures
- Sales: 43,673百万円（前年同期比3.3％増）
- Operating profit: 2,557百万円（前年同期比10.4％増）
- Ordinary profit: 2,650百万円（前年同期比10.5％増）
AI要約
Overview of Results
Mid-year results for this term were solid. Net sales were 43,673 million yen (up 3.3% YoY), operating profit 2,557 million yen, ordinary profit 2,650 million yen, and net income attributable to owners of the parent 1,970 million yen, achieving increases in both sales and profit. By segment, the liquor business performed well, though increases in raw material costs and selling, general, and administrative expenses affected profits. Enzyme medicines saw solid growth from overseas sales. Enzyme medicines and real estate were major contributors. The full-year outlook remains unchanged from previous guidance.
Shareholder Returns / Financial Position
Treasury stock was acquired during the interim period, with ending treasury stock of 3,151 million yen and 649,300 shares acquired. Cash and cash equivalents stood at 826 million yen. The equity ratio improved to 49.2% from the previous term end. Cash flows: operating activities were positive, investing activities were negative due to asset purchases, and financing activities were negative due to increased borrowings and distributions including dividends and treasury stock acquisitions.
Oenon Holdings, Inc.
Company overview · Stock price · Financial data · All IR
